On page 407 in the abstract and on page 410 under “Phase 1b,” the incorrect phase 2 dose of lenalidomide was cited. The correct dose should be 15 mg, not 20 mg.
© 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
2024
